Xencor Inc
XNCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326732
No open-market purchases or sales by Xencor Inc insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Xencor Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 198
- 0 vs. Q1 2024
- Shares held
- 63.6M
- −1.24M (−1.9%) vs. Q1 2024
- Total value
- $1.20B
- −$231.3M (−16.1%) vs. Q1 2024
- New holders
- 25
- 65 more added
- Sold out
- 25
- 70 more reduced
3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XNCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $1.36B |
| Q1 2026 | 203 | $1.02B |
| Q4 2025 | 208 | $1.25B |
| Q3 2025 | 206 | $960.2M |
| Q2 2025 | 194 | $646.9M |
| Q1 2025 | 202 | $837.9M |
| Q4 2024 | 192 | $1.72B |
| Q3 2024 | 210 | $1.45B |
| Q2 2024 | 198 | $1.20B |
| Q1 2024 | 201 | $1.44B |
| Q4 2023 | 195 | $1.35B |
| Q3 2023 | 178 | $1.27B |
| Q2 2023 | 182 | $1.57B |
| Q1 2023 | 188 | $1.77B |
| Q4 2022 | 197 | $1.60B |
| Q3 2022 | 186 | $1.58B |
| Q2 2022 | 176 | $1.64B |
| Q1 2022 | 181 | $1.58B |
| Q4 2021 | 178 | $2.37B |
| Q3 2021 | 170 | $1.90B |
| Q2 2021 | 178 | $2.00B |
| Q1 2021 | 170 | $2.52B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Xencor Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −107,774−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −104,404−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −69,863−100.0% | Sold out |
| Texas Permanent School Fund | 0 | $0 | 0.00% | −53,277−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −34,336−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −31,408−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −25,886−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −21,300−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −18,968−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −17,246−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −16,562−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −15,118−100.0% | Sold out |
| Natixis Advisors, L.P. | 0 | $0 | 0.00% | −11,222−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −10,839−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,776−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −10,347−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,400−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,060−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −383−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Oracle Alpha Inc. | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |